Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling Final rule äFed Regist 2007[Dec]; 72 (243): 71769-85The Food and Drug Administration (FDA) is issuing a final rule establishing new warning statements and other labeling information for all over-the-counter (OTC) vaginal contraceptive drug products (also known as spermicides, hereinafter referred to as vaginal contraceptives or vaginal contraceptives/spermicides) containing nonoxynol 9 (N9). These warning statements will advise consumers that vaginal contraceptives/spermicides containing N9 do not protect against infection from the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), or against getting other sexually transmitted diseases (STDs). The warnings and labeling information will also advise consumers that use of vaginal contraceptives and spermicides containing N9 can irritate the vagina and rectum and may increase the risk of getting the AIDS virus (HIV) from an infected partner. This final rule is part of FDA's ongoing review of OTC drug products. FDA is issuing this final rule after considering public comments on its proposed regulation, and all relevant data and information on N9 that have come to our attention.|*Contraceptive Agents/administration & dosage/adverse effects/therapeutic use[MESH]|*Nonoxynol/administration & dosage/adverse effects/therapeutic use[MESH]|*Spermatocidal Agents/administration & dosage/adverse effects/therapeutic use[MESH]|Condoms[MESH]|Drug Labeling/*legislation & jurisprudence[MESH]|Female[MESH]|HIV Infections/prevention & control/transmission[MESH]|Humans[MESH]|Male[MESH]|Nonprescription Drugs/administration & dosage/adverse effects/therapeutic use[MESH]|Sexually Transmitted Diseases/prevention & control/transmission[MESH]|United States[MESH] |